Bio-Thera Solutions, Ltd. — Investor Relations & Filings
About Bio-Thera Solutions, Ltd.
Bio-Thera Solutions, Ltd. is a biopharmaceutical company dedicated to the research and development of innovative therapeutics and high-quality biosimilars. The company focuses on addressing serious medical conditions across oncology, autoimmune, and cardiovascular therapeutic areas. Its portfolio includes several approved biosimilars, such as QLETLI (adalimumab), POBEVCY (bevacizumab), and TOFIDENCE (tocilizumab), alongside a robust pipeline of novel drug candidates, including antibody-drug conjugates (ADCs) and monoclonal antibodies. Bio-Thera utilizes advanced technology platforms to streamline the drug discovery and development process, aiming to expand global access to essential biologic medicines. The organization maintains a commitment to rigorous clinical standards and international regulatory compliance to deliver effective treatment options for patients worldwide.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 百奥泰 2024年年度股东大会会议资料 | 2025-04-15 | Chinese | |
| 百奥泰生物制药股份有限公司对外投资管理制度 | 2025-04-08 | Chinese | |
| 百奥泰 关于公司2025年度董事和高级管理人员薪酬方案的公告 | 2025-04-08 | Chinese | |
| 百奥泰生物制药股份有限公司章程 | 2025-04-08 | Chinese | |
| 百奥泰生物制药股份有限公司股东会议事规则 | 2025-04-08 | Chinese | |
| 百奥泰生物制药股份有限公司独立董事候选人声明与承诺（廖健） | 2025-04-08 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 39230330 | 百奥泰 2024年年度股东大会会议资料 | 2025-04-15 | Chinese | ||
| 39230311 | 百奥泰生物制药股份有限公司对外投资管理制度 | 2025-04-08 | Chinese | ||
| 39230306 | 百奥泰 关于公司2025年度董事和高级管理人员薪酬方案的公告 | 2025-04-08 | Chinese | ||
| 39230298 | 百奥泰生物制药股份有限公司章程 | 2025-04-08 | Chinese | ||
| 39230290 | 百奥泰生物制药股份有限公司股东会议事规则 | 2025-04-08 | Chinese | ||
| 39230280 | 百奥泰生物制药股份有限公司独立董事候选人声明与承诺（廖健） | 2025-04-08 | Chinese | ||
| 39230251 | 百奥泰 关于向金融机构申请授信额度的公告 | 2025-04-08 | Chinese | ||
| 39230245 | 百奥泰 2024年度独立董事述职报告（汪建平） | 2025-04-08 | Chinese | ||
| 39230240 | 百奥泰 2024年度董事会审计委员会履职情况报告 | 2025-04-08 | Chinese | ||
| 39230231 | 百奥泰生物制药股份有限公司董事会议事规则 | 2025-04-08 | Chinese | ||
| 39230222 | 百奥泰生物制药股份有限公司独立董事工作制度 | 2025-04-08 | Chinese | ||
| 39230212 | 百奥泰 2024年年度报告 | 2025-04-08 | Chinese | ||
| 39230183 | 百奥泰生物制药股份有限公司独立董事提名人声明与承诺（柳建华） | 2025-04-08 | Chinese | ||
| 39230168 | 百奥泰生物制药股份有限公司独立董事候选人声明与承诺（陈旻湖） | 2025-04-08 | Chinese | ||
| 39230147 | 百奥泰 2024年年度报告摘要 | 2025-04-08 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Bio-Thera Solutions, Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58210/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58210 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58210 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58210 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58210}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Bio-Thera Solutions, Ltd. (id: 58210)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.